The CUSUM test applied in prospective nuchal translucency quality review

被引:17
|
作者
Sabria, J. [1 ]
Barcelo-Vidal, C. [2 ]
Arigita, M. [3 ,4 ]
Jimenez, J. M. [3 ,4 ]
Puerto, B. [3 ,4 ]
Borrell, A. [3 ,4 ]
机构
[1] Hosp St Joan de Deu, Serv Obstet & Ginecol, Dept Obstet & Gynecol, Barcelona 08950, Catalonia, Spain
[2] Univ Girona, Dept Comp Sci & Appl Math, Girona, Catalonia, Spain
[3] Hosp Clin Barcelona, Inst Gynecol Obstet & Neonatol, Ultrasound Unit, Barcelona, Catalonia, Spain
[4] Hosp Clin Barcelona, Inst Gynecol Obstet & Neonatol, Prenatal Diag Unit, Barcelona, Catalonia, Spain
关键词
CUSUM; Down syndrome; nuchal translucency; prenatal screening; quality assurance; ULTRASOUND;
D O I
10.1002/uog.8860
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objectives To design a cumulative sum (CUSUM) test for prospective nuchal translucency (NT) measurement quality review that is as stringent as the retrospective quality review methods based on distribution parameters currently in use. Methods The database including all fetal NT measurements obtained during a 2-year period in a single center was reviewed, and measurements obtained by sonologists who measured fewer than 100 cases were excluded. The NT distribution parameters proposed by The Fetal Medicine Foundation (FMF) and the Women & Infants Hospital of Rhode Island (WIHRI) were assessed in the whole NT series and in sonologist-specific distributions. A previously described CUSUM model was adapted to fulfil our objective. Results Two thousand four hundred and seventy-five NT measurements were obtained by seven sonologists during the study period (January 2007-December 2008). In the assessment of sonologist-specific NT distributions, two sonologists fulfilled all the FMF and WIHRI criteria, one showed NT overestimation and four failed due to NT underestimation. Our new CUSUM test model, based on multiples of the median deviations, showed good agreement with the FMF and WIHRI methods in the assessment of sonologist-specific performance. Conclusions Our CUSUM test model showed close agreement with the retrospective quality review methods based on distribution parameters currently in use, but with the advantage that it can be applied prospectively, allowing for earlier correction of deviations from target performance. Copyright (C) 2011 ISUOG. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:582 / 587
页数:6
相关论文
共 50 条
  • [41] Blood and lymphatic vessels in fetuses with increased nuchal translucency at 11-14 weeks' gestation: A review
    von Kaisenberg, CS
    Nicolaides, KH
    Brand-Saberi, B
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2004, 64 (11) : 1167 - 1176
  • [42] Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review
    Petersen, Olav B.
    Smith, Eric
    Van Opstal, Diane
    Polak, Marike
    Knapen, Maarten F. C. M.
    Diderich, Karin E. M.
    Bilardo, Caterina M.
    Arends, Lidia R.
    Vogel, Ida
    Srebniak, Malgorzata, I
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (06) : 765 - 774
  • [43] A DOWN SYNDROME FEMALE INFANT WITH PARTIAL TRISOMY OF CHROMOSOME 21-ABNORMAL NUCHAL TRANSLUCENCY SCREENING TEST
    Strah, D.
    Veble, A.
    Rudolf, G.
    Writzl, K.
    Gersak, K.
    GENETIC COUNSELING, 2008, 19 (04): : 429 - 432
  • [44] Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis
    Prats, Pilar
    Rodriguez, Ignacio
    Comas, Carmina
    Puerto, Bienvenido
    PRENATAL DIAGNOSIS, 2014, 34 (11) : 1077 - 1083
  • [45] Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population
    Scott, F
    Peters, H
    Bonifacio, M
    Mclennan, A
    Boogert, A
    Kesby, G
    Anderson, J
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2004, 44 (03) : 205 - 209
  • [46] Quality assurance in prenatal screening for aneuploidies. epidemiologic assessment and quality control in nuchal translucency measurements: Results in a tertiary hospital over a 3-year period
    Paraiso Torras, B.
    Carretero Gomez, J. F.
    Maldonado del Valle, M. D.
    Penalver Marquina, I.
    Canete Palomo, M. L.
    CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2016, 43 (04): : 150 - 153
  • [47] First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique
    Snijders, RJM
    Thom, EA
    Zachary, JM
    Platt, LD
    Greene, N
    Jackson, LG
    Sabbagha, RE
    Filkins, K
    Silver, RK
    Hogge, WA
    Ginsberg, NA
    Beverly, S
    Morgan, P
    Blum, K
    Chilis, P
    Hill, LM
    Hecker, J
    Wapner, RJ
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2002, 19 (04) : 353 - 359
  • [48] Prenatal detection of full monosomy 21 in a fetus with increased nuchal translucency: Molecular cytogenetic analysis and review of the literature
    Manolakos, Emmanouil
    Peitsidis, Panagiotis
    Eleftheriades, Makarios
    Dedoulis, Evaggelos
    Ziegler, Monika
    Orru, Sandro
    Liehr, Thomas
    Petersen, Michael B.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (02) : 435 - 440
  • [49] Increased nuchal translucency after low-risk noninvasive prenatal testing: What should we tell prospective parents?
    Kelley, Joanne
    McGillivray, George
    Meagher, Simon
    Hui, Lisa
    PRENATAL DIAGNOSIS, 2021, 41 (10) : 1305 - 1315
  • [50] Does diurnal variation affect the first trimester fetal aneuploidy screening test biochemical parameters of fetuses with normal nuchal translucency?
    Karsli, Mehmet Fatih
    Cakmak, Bulent
    Seckin, Kerem Doga
    Yilmaz, Elif Akkas
    Akgul, Gurcan
    Togrul, Cihan
    Kucukozkan, Tuncay
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (11) : 1808 - 1811